Tapewire

Nasdaq · USD

BMRN

BIOMARIN PHARMACEUTICAL INC

Export transactions ↓
Tapewire entity
2404
SEC CIK
0001048477
Parsed reports
685

Last 12 months

Inside the activity.

0 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202601
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 26, 2018 Filed Mar 1, 2018 01:57 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
GrantCommon Stock 12,529 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-011000 · doc1.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,129

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2017 as set forth in the Issuer's audited financial statements.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 22, 2018, 2019 and 2020, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.

Read SEC document
February 26, 2018 Filed Mar 1, 2018 01:52 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantCommon Stock 12,529 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-010991 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,918

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2017 as set forth in the Issuer's audited financial statements.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 22, 2018, 2019 and 2020, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.

F4 · balance_after: Amount of securities beneficially owned has been updated from the reporting person's prior report to exclude 555 shares inadvertently included in prior reports based on a reconciliation with the Company's records.

Read SEC document
February 26, 2018 Filed Mar 1, 2018 01:44 UTC
BAFFI ROBERTEVP, Technical Operations
GrantCommon Stock 12,190 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-010977 · doc1.xml · nonDerivative · entry 1

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,084

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 22, 2018, 2019 and 2020, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2017 as set forth in the Issuer's audited financial statements.

F4 · balance_after: Amount of securities beneficially owned has been updated from the reporting person's prior report to: a) exclude 55,663 shares reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017; and b) exclude 4,526 shares inadvertently included in prior reports based on a reconciliation with the Company's records.

Read SEC document
February 26, 2018 Filed Apr 27, 2018 01:04 UTC Amendment
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
GrantCommon Stock 12,615 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-019878 · doc1.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,215

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2017 as set forth in the Issuer's audited financial statements.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 22, 2018, 2019 and 2020, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.

F4 · shares: This amendment is being filed solely to correct an administrative error in the original filing regarding the number of RSUs reported as earned.

Read SEC document
February 26, 2018 Filed Apr 27, 2018 00:55 UTC Amendment
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantCommon Stock 12,615 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-019870 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,004

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2017 as set forth in the Issuer's audited financial statements.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 22, 2018, 2019 and 2020, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.

F4 · shares: This amendment is being filed solely to correct an administrative error in the original filing regarding the number of RSUs reported as earned.

F5 · balance_after: Amount of securities beneficially owned has been updated from the reporting person's prior report to exclude 555 shares inadvertently included in prior reports based on a reconciliation with the Company's records.

Read SEC document
February 26, 2018 Filed Apr 27, 2018 00:47 UTC Amendment
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GrantCommon Stock 46,034 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-019863 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,528

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2017 as set forth in the Issuer's audited financial statements.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 22, 2018, 2019 and 2020, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.

F4 · shares: This amendment is being filed solely to correct an administrative error in the original filing regarding the number of RSUs reported as earned.

Read SEC document
February 26, 2018 Filed Apr 27, 2018 00:38 UTC Amendment
BAFFI ROBERTEVP, Technical Operations
GrantCommon Stock 12,274 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-019858 · doc1.xml · nonDerivative · entry 1

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,168

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 22, 2018, 2019 and 2020, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2017 as set forth in the Issuer's audited financial statements.

F4 · shares: This amendment is being filed solely to correct an administrative error in the original filing regarding the number of RSUs reported as earned.

F5 · balance_after: Amount of securities beneficially owned has been updated from the reporting person's prior report to: a) exclude 55,663 shares reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017; and b) exclude 4,526 shares inadvertently included in prior reports based on a reconciliation with the Company's records.

Read SEC document
February 26, 2018 Filed Apr 27, 2018 00:30 UTC Amendment
FUCHS HENRY JPresident, Worldwide R&D
GrantCommon Stock 20,463 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-019854 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,024

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 22, 2018, 2019 and 2020, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2017 as set forth in the Issuer's audited financial statements.

F4 · shares: This amendment is being filed solely to correct an administrative error in the original filing regarding the number of RSUs reported as earned.

Read SEC document
February 26, 2018 Filed Apr 27, 2018 00:20 UTC Amendment
Davis George EricEVP, General Counsel
GrantCommon Stock 11,601 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-019851 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,343

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2017 as set forth in the Issuer's audited financial statements.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 22, 2018, 2019 and 2020, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.

F4 · shares: This amendment is being filed solely to correct an administrative error in the original filing regarding the number of RSUs reported as earned.

Read SEC document
February 15, 2018 Filed Feb 21, 2018 01:40 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 10,000 $0.00 Strike: $38.59 $0.00
Disclosure

SEC source: 0001140361-18-009201 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,500

Underlying: Common Stock · 10,000 shares

Expires 2018-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

F5 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
February 15, 2018 Filed Feb 21, 2018 01:40 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 10,000 $84.63 $846,285.00
Disclosure

SEC source: 0001140361-18-009201 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 226,494

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

F2 · price: The price in column 4 is the weighted average price. The price actually received ranged from $84.095 to $84.98. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

F3 · balance_after: Amount of securities beneficially owned has been updated from the reporting person's prior report to include 600 shares reported in the Form 4 Amendment filed with the S.E.C. on 01/02/2018.

Read SEC document
February 15, 2018 Filed Feb 21, 2018 01:40 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 10,000 $38.59 $385,900.00
Disclosure

SEC source: 0001140361-18-009201 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 236,494

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

F3 · balance_after: Amount of securities beneficially owned has been updated from the reporting person's prior report to include 600 shares reported in the Form 4 Amendment filed with the S.E.C. on 01/02/2018.

Read SEC document
February 01, 2018 Filed Feb 6, 2018 01:13 UTC
Davis George EricEVP, General Counsel
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 30,000 $0.00 Strike: $38.59 $0.00
Disclosure

SEC source: 0001140361-18-005181 · doc1.xml · derivative · entry 3

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2018-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on June 9, 2017.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
February 01, 2018 Filed Feb 6, 2018 01:13 UTC
Davis George EricEVP, General Counsel
SaleCommon Stock 30,000 $90.66 $2,719,665.00
Disclosure

SEC source: 0001140361-18-005181 · doc1.xml · nonDerivative · entry 2

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,942

F1 · date: Trade made pursuant to a 10b5-1 plan executed on June 9, 2017.

F2 · price: The price in column 4 is the weighted average price. The price actually received ranged from $90.00 to $91.86. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
February 01, 2018 Filed Feb 6, 2018 01:13 UTC
Davis George EricEVP, General Counsel
Exercise / conversionCommon Stock 30,000 $38.59 $1,157,700.00
Disclosure

SEC source: 0001140361-18-005181 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,942

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on June 9, 2017.

F2 · price: The price in column 4 is the weighted average price. The price actually received ranged from $90.00 to $91.86. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
January 05, 2018 Filed Jan 10, 2018 01:36 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 10,000 $0.00 Strike: $38.59 $0.00
Disclosure

SEC source: 0001140361-18-001507 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,500

Underlying: Common Stock · 10,000 shares

Expires 2018-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
January 05, 2018 Filed Jan 10, 2018 01:36 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 10,000 $90.32 $903,203.00
Disclosure

SEC source: 0001140361-18-001507 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,894

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

F2 · price: The price in column 4 is the weighted average price. The price actually received ranged from $89.81 to $90.82. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
January 05, 2018 Filed Jan 10, 2018 01:36 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 10,000 $38.59 $385,900.00
Disclosure

SEC source: 0001140361-18-001507 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,894

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

Read SEC document
January 02, 2018 Filed Jan 5, 2018 00:26 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (right to buy Common Stock) · Derivative 10,000 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001140361-18-000914 · doc1.xml · derivative · entry 5

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,331

Underlying: Common Stock · 10,000 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F4 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
January 02, 2018 Filed Jan 5, 2018 00:26 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionStock Option (right to buy Common Stock) · Derivative 5,000 $0.00 Strike: $26.49 $0.00
Disclosure

SEC source: 0001140361-18-000914 · doc1.xml · derivative · entry 4

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,225

Underlying: Common Stock · 5,000 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F4 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
January 02, 2018 Filed Jan 5, 2018 00:26 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 15,000 $89.23 $1,338,400.50
Disclosure

SEC source: 0001140361-18-000914 · doc1.xml · nonDerivative · entry 3

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,976

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F3 · price: The price in column 4 is the weighted average price. The price actually received ranged from $88.84 to $90.00. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
January 02, 2018 Filed Jan 5, 2018 00:26 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionCommon Stock 10,000 $37.46 $374,600.00
Disclosure

SEC source: 0001140361-18-000914 · doc1.xml · nonDerivative · entry 2

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,976

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

Read SEC document
January 02, 2018 Filed Jan 5, 2018 00:26 UTC
FUCHS HENRY JPresident, Worldwide R&D
Exercise / conversionCommon Stock 5,000 $26.49 $132,450.00
Disclosure

SEC source: 0001140361-18-000914 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,976

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F2 · balance_after: Amount of securities beneficially owned has been updated from the reporting person's prior report to: a) exclude 1,435 shares as previously reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017; and b) exclude 1,011 shares inadvertently included in prior reports based on a reconciliation with the Company's records.

Read SEC document
January 02, 2018 Filed Jan 5, 2018 01:16 UTC Exercise / conversionStock Option (right to buy Common Stock) · Derivative 3,750 $0.00 Strike: $38.59 $0.00
Disclosure

SEC source: 0001140361-18-000921 · doc1.xml · derivative · entry 3

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires 2018-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F4 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
January 02, 2018 Filed Jan 5, 2018 01:16 UTC SaleCommon Stock 3,750 $88.84 $333,150.00
Disclosure

SEC source: 0001140361-18-000921 · doc1.xml · nonDerivative · entry 2

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,860

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F3 · price: All shares sold at the same price.

F2 · balance_after: Amount of securities beneficially owned has been updated from the reporting person's prior report to exclude 1,050 shares as previously reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017.

Read SEC document
January 02, 2018 Filed Jan 5, 2018 01:16 UTC Exercise / conversionCommon Stock 3,750 $38.59 $144,712.50
Disclosure

SEC source: 0001140361-18-000921 · doc1.xml · nonDerivative · entry 1

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,610

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F2 · balance_after: Amount of securities beneficially owned has been updated from the reporting person's prior report to exclude 1,050 shares as previously reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017.

Read SEC document
December 29, 2017 Filed Jan 2, 2018 22:29 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 10,000 $0.00 Strike: $38.59 $0.00
Disclosure

SEC source: 0001140361-18-000232 · doc1.xml · derivative · entry 9

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,500

Underlying: Common Stock · 10,000 shares

Expires 2018-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

F5 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
December 29, 2017 Filed Jan 2, 2018 22:29 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 10,000 $89.61 $896,125.00
Disclosure

SEC source: 0001140361-18-000232 · doc1.xml · nonDerivative · entry 6

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,894

F3 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

F6 · price: The price in column 4 is the weighted average price. The price actually received ranged from $88.97 to $90.45. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
December 29, 2017 Filed Jan 2, 2018 22:29 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 10,000 $38.59 $385,900.00
Disclosure

SEC source: 0001140361-18-000232 · doc1.xml · nonDerivative · entry 5

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,894

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

Read SEC document
December 28, 2017 Filed Jan 2, 2018 22:29 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 10,000 $0.00 Strike: $38.59 $0.00
Disclosure

SEC source: 0001140361-18-000232 · doc1.xml · derivative · entry 8

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,500

Underlying: Common Stock · 10,000 shares

Expires 2018-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

F5 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
December 28, 2017 Filed Jan 2, 2018 22:29 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 10,000 $89.89 $898,912.00
Disclosure

SEC source: 0001140361-18-000232 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,894

F3 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

F4 · price: The price in column 4 is the weighted average price. The price actually received ranged from $88.89 to $90.92. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
December 28, 2017 Filed Jan 2, 2018 22:29 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 10,000 $38.59 $385,900.00
Disclosure

SEC source: 0001140361-18-000232 · doc1.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,894

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · date: Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.

Read SEC document
December 14, 2017 Filed Dec 19, 2017 01:56 UTC SaleCommon Stock 800 $88.90 $71,116.00
Disclosure

SEC source: 0001140361-17-046612 · doc1.xml · nonDerivative · entry 1

HERON ELAINE J · CIK 0001235471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,385

F1 · price: All shares sold at the same price.

Read SEC document
December 14, 2017 Filed Jan 2, 2018 22:29 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GiftCommon Stock 600 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-000232 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,894

F2 · date: On December 14, 2017, the reporting person gifted 600 shares to an educational institution.

Read SEC document
December 14, 2017 Filed Feb 21, 2018 01:33 UTC Amendment
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GiftCommon Stock 600 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-009199 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares held by Jean-Jacques Bienaime Family Trust

Disclosed balance after: 182,201

F1 · date: On December 14, 2017, the reporting person gifted 600 shares to an educational institution.

F2 · balance_after: On January 2, 2018, the reporting person filed a Form 4 which inadvertently reported the gift as made from the reporting person and not from the reporting person's trust. This amendment corrects such error.

Read SEC document
November 30, 2017 Filed Dec 5, 2017 01:26 UTC
Davis George EricEVP, General Counsel
SaleCommon Stock 1,200 $85.64 $102,766.80
Disclosure

SEC source: 0001140361-17-044957 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,942

F1 · price: All shares sold at the same price.

F2 · balance_after: Amount of securities beneficially owned has been updated from the reporting person's prior report to: a) include 804 shares reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017; and b) exclude 243 shares inadvertently included in prior reports based on a reconciliation with the Company's records.

Read SEC document
November 22, 2017 Filed Feb 15, 2018 01:38 UTC
Davis George EricEVP, General Counsel
GiftCommon Stock 200 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-008560 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,742

F1 · date: On November 22, 2017 the reporting person gifted 200 shares to an educational institution.

Read SEC document
October 31, 2017 Filed Feb 15, 2018 01:30 UTC
Mueller BrianSVP, Corporate Controller
GrantCommon Stock 33 $69.78 $2,302.64
Disclosure

SEC source: 0001140361-18-008558 · doc1.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,918

F1 · date: Represents shares acquired by the reporting person on October 31, 2017, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
October 31, 2017 Filed Feb 15, 2018 01:23 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
GrantCommon Stock 162 $69.78 $11,303.87
Disclosure

SEC source: 0001140361-18-008551 · doc1.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,600

F1 · date: Represents shares acquired by the reporting person on October 31, 2017, pursuant to the issuer's Employee Stock Purchase Plan.

F2 · balance_after: Amount of securities beneficially owned has been updated from the reporting person's prior report to: a) include 34,078 shares reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017; and b) include 57 shares inadvertently excluded in prior reports based on a reconciliation with the Company's records.

Read SEC document
September 29, 2017 Filed Oct 4, 2017 00:11 UTC GrantCommon Stock 3,180 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-037507 · doc1.xml · nonDerivative · entry 1

HOMBACH ROBERT J. · CIK 0001496182 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,180

F1 · price: Restricted stock units granted on September 29, 2017 represent a pro rata share of the 2017 annual award for independent directors and vest on June 6, 2018, the same vesting date for the 2017 annual award for all other independent directors.

Read SEC document
September 28, 2017 Filed Oct 3, 2017 01:07 UTC
BAFFI ROBERTEVP, Technical Operations
SaleCommon Stock 2,915 $92.06 $268,354.90
Disclosure

SEC source: 0001140361-17-037214 · doc1.xml · nonDerivative · entry 2

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares held by Baffi Family Trust

Disclosed balance after: 28,761

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 12, 2017.

F1 · deemedExecutionDate: Trade made pursuant to a 10b5-1 plan executed on September 12, 2017.

F3 · price: All shares sold at the same price.

Read SEC document
September 28, 2017 Filed Oct 3, 2017 01:07 UTC
BAFFI ROBERTEVP, Technical Operations
SaleCommon Stock 15,500 $92.50 $1,433,675.60
Disclosure

SEC source: 0001140361-17-037214 · doc1.xml · nonDerivative · entry 1

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,083

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 12, 2017.

F1 · deemedExecutionDate: Trade made pursuant to a 10b5-1 plan executed on September 12, 2017.

F2 · price: The price in column 4 is the weighted average price. The price actually received ranged from $91.92 to $92.90. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
September 26, 2017 Filed Jan 2, 2018 22:29 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GiftCommon Stock 430 $0.00 $0.00
Disclosure

SEC source: 0001140361-18-000232 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 226,494

F1 · date: On September 26, 2017, the reporting person gifted 430 shares to an educational institution.

Read SEC document
September 22, 2017 Filed Sep 26, 2017 23:19 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 2,166 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001140361-17-036526 · doc1.xml · derivative · entry 6

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,166 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 6, 2017.

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
September 22, 2017 Filed Sep 26, 2017 23:19 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 1,355 $0.00 Strike: $37.46 $0.00
Disclosure

SEC source: 0001140361-17-036526 · doc1.xml · derivative · entry 5

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,166

Underlying: Common Stock · 1,355 shares

Expires 2022-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 6, 2017.

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
September 22, 2017 Filed Sep 26, 2017 23:19 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
SaleCommon Stock 2,166 $95.00 $205,770.00
Disclosure

SEC source: 0001140361-17-036526 · doc1.xml · nonDerivative · entry 4

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,944

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 6, 2017.

F2 · price: All shares were sold at the same price.

Read SEC document
September 22, 2017 Filed Sep 26, 2017 23:19 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
Exercise / conversionCommon Stock 2,166 $37.46 $81,138.36
Disclosure

SEC source: 0001140361-17-036526 · doc1.xml · nonDerivative · entry 3

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,110

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 6, 2017.

Read SEC document
September 22, 2017 Filed Sep 26, 2017 23:19 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
SaleCommon Stock 1,355 $95.00 $128,725.00
Disclosure

SEC source: 0001140361-17-036526 · doc1.xml · nonDerivative · entry 2

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,944

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 6, 2017.

F2 · price: All shares were sold at the same price.

Read SEC document
September 22, 2017 Filed Sep 26, 2017 23:19 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
Exercise / conversionCommon Stock 1,355 $37.46 $50,758.30
Disclosure

SEC source: 0001140361-17-036526 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,299

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 6, 2017.

Read SEC document
September 15, 2017 Filed Sep 19, 2017 19:27 UTC Exercise / conversionStock Option (right to buy) Common Stock · Derivative 3,750 $0.00 Strike: $38.59 $0.00
Disclosure

SEC source: 0001140361-17-035905 · doc1.xml · derivative · entry 3

LAWLIS V BRYAN · CIK 0001247681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 3,750 shares

Expires 2018-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.